Literature DB >> 1425712

Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988.

A Bucher1, P R Martin, E A Høiby, A Halstensen, A Odegaard, K B Hellum, L Westlie, S Hallan.   

Abstract

All 87 known cases of bacteraemia due to Streptococcus pyogenes (beta-haemolytic group A streptococci) occurring during the peak of a nationwide outbreak in Norway (population 4.2 million) between January and June 1988 were reviewed. Clinical features varied widely and appeared largely to be dependent on the patients' age. The case fatality rate ranged from 11% in the age group under 30 years to 44% in patients over 60 years. Clinical complications such as shock, severe renal or respiratory failure or serious local infection occurred particularly in 30-to 59-year old individuals. Shock was manifest in 32% of the patients and carried a 68% case fatality rate. Chronic heart disease in the elderly and pneumonia seemed to be associated with a fatal outcome. In the 25 patients (29%) who died the disease showed a fulminant course, 80% dying within 48 hours after admission. However, 56% of the patients had experienced symptoms for more than two days before admission, suggesting that early diagnosis and treatment might possibly have prevented the development of a serious disease. This study revealed a wide spectrum of clinical manifestations in bacteraemia cases in a unique epidemiological situation caused largely by a single serotype of Streptococcus pyogenes; 89% of the 27 preserved bacteraemia strains carried the M-1 antigen. The observations call attention to the ability of these organisms to cause fulminant clinical illness, indicating a probable increase in both invasiveness and toxicity of group A streptococci responsible for the epidemic.

Entities:  

Mesh:

Year:  1992        PMID: 1425712     DOI: 10.1007/bf01961856

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Toxic shock-like syndrome associated with necrotizing Streptococcus pyogenes infection.

Authors:  T J Connolly; D J Pavelka; E F Lanspa; T L Connolly
Journal:  Henry Ford Hosp Med J       Date:  1989

2.  Streptococcus pyogenes and the toxic shock syndrome.

Authors:  V Hríbalová
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

Review 3.  Invasive streptococcal infections in the era before the acquired immune deficiency syndrome: a 10 years' compilation of patients with streptococcal bacteraemia in North Yorkshire.

Authors:  M Barnham
Journal:  J Infect       Date:  1989-05       Impact factor: 6.072

Review 4.  Cryptogenic group A streptococcal bacteremia: experience at an urban general hospital and review of the literature.

Authors:  M R Bibler; G W Rouan
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

5.  Bacteraemia in streptococcal infections of the throat.

Authors:  M Barnham
Journal:  J Infect       Date:  1983-11       Impact factor: 6.072

6.  Resurgence of acute rheumatic fever in the intermountain area of the United States.

Authors:  L G Veasy; S E Wiedmeier; G S Orsmond; H D Ruttenberg; M M Boucek; S J Roth; V F Tait; J A Thompson; J A Daly; E L Kaplan
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

7.  'Toxic strep syndrome'. A manifestation of group A streptococcal infection.

Authors:  T Bartter; A Dascal; K Carroll; F J Curley
Journal:  Arch Intern Med       Date:  1988-06

8.  Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated.

Authors:  P Ispahani; F E Donald; A J Aveline
Journal:  J Infect       Date:  1988-01       Impact factor: 6.072

9.  [Streptococcus (S. pyogenes) group A septicemia. Analysis of 20 cases in adults].

Authors:  B Dubey; P Francioli; S Poli; M P Glauser
Journal:  Schweiz Med Wochenschr       Date:  1983-01-15

Review 10.  Streptococcal toxins.

Authors:  L W Wannamaker
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct
View more
  6 in total

1.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.

Authors:  Waleed Nasser; Stephen B Beres; Randall J Olsen; Melissa A Dean; Kelsey A Rice; S Wesley Long; Karl G Kristinsson; Magnus Gottfredsson; Jaana Vuopio; Kati Raisanen; Dominique A Caugant; Martin Steinbakk; Donald E Low; Allison McGeer; Jessica Darenberg; Birgitta Henriques-Normark; Chris A Van Beneden; Steen Hoffmann; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

2.  First reported case of Streptococcus pyogenes infection with toxic shock-like syndrome in Italy.

Authors:  G B Cherchi; E L Kaplan; P M Schlievert; A Bitti; G Orefici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

3.  Cardiac myocyte dysfunction induced by streptolysin O is membrane pore and calcium dependent.

Authors:  Devin D Bolz; Zhi Li; Eric R McIndoo; Rodney K Tweten; Amy E Bryant; Dennis L Stevens
Journal:  Shock       Date:  2015-02       Impact factor: 3.454

4.  Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.

Authors:  Roger Meisal; Ida K G Andreasson; E Arne Høiby; Ingeborg S Aaberge; Terje E Michaelsen; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

5.  Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.

Authors:  B Vlaminckx; W van Pelt; L Schouls; A van Silfhout; C Elzenaar; E Mascini; J Verhoef; J Schellekens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

6.  Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities.

Authors:  Andrea Smith; Aimin Li; Ornella Tolomeo; Gregory J Tyrrell; Frances Jamieson; David Fisman
Journal:  Emerg Infect Dis       Date:  2003-10       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.